Personalized haemodynamic modelling for non-invasive quantification of arterial stiffness in the human vasculature
Journal of the Royal Society Interface · 2026
DOI: 10.1098/rsif.2025.1318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Royal Society Interface, 2026. Verfasst von Xiangdong Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences , Shenzhen, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Vascular Stiffness, Models, Cardiovascular, Hemodynamics, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Medical Research Fund, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Arterial stiffness is a pivotal predictor of cardiovascular events, yet its in vivo characterization remains elusive because arterial wall mechanics cannot be directly measured. Conventional inverse approaches require high-resolution imaging to resolve wall motion, restricting their clinical applicability. Here, we present a non-invasive computational framework that infers regional arterial stiffness solely from routinely acquired pressure and blood flow velocity waveforms by leveraging personalized one-dimensional haemodynamic models of the human arterial network. Patient-specific models were constructed for 21 individuals with hypertension using stroke volume, arterial diameters, brachial pressures and carotid flow profiles. Regional stiffness parameters were identified through optimization to reconcile simulated and measured haemodynamics, and validated against brachial-ankle pulse wave velocity. The inferred stiffness demonstrated strong concordance with clinical measurements (r = 0.81; standard error = 279 cm s)–1. Longitudinal evaluation in 13 patients further revealed therapy-dependent remodelling, with calcium channel blockers selectively reducing pathological stiffening while preserving compliant vessels. Together, these results establish model-based inversion of standard haemodynamic data as a practical, scalable approach for quantifying arterial stiffness, enabling individualized cardiovascular risk assessment and treatment monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Institutes of Advanced Technology Chinese Academy of Sciences , Shenzhen, Guangdong, People's Republic of China.
- Shenzhen Institutes for Advanced Study UESTC , Shenzhen, Guangdong, People's Republic of China.
- Futian Center for Chronic Disease Control , Shenzhen, People's Republic of China.
- Department of Electronics and Mechanical Engineering, Chiba University , Chiba, Japan.
- Shenzhen University of Advanced Technology , Shenzhen, Guangdong, People's Republic of China.
ORCID-Profile: Xiangdong Zhang, Hao Liu
Förderung
- Shenzhen Medical Research Fund
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Basic Research Foundation
Zitieren
APA
Zhang, X., Wu, D., Miao, F., Zhong, J., Yu, F., Zhang, X., Liu, H., & Li, Y. (2026). Personalized haemodynamic modelling for non-invasive quantification of arterial stiffness in the human vasculature. Journal of the Royal Society Interface. https://doi.org/10.1098/rsif.2025.1318
Vancouver
Zhang X, Wu D, Miao F, Zhong J, Yu F, Zhang X, et al. Personalized haemodynamic modelling for non-invasive quantification of arterial stiffness in the human vasculature. Journal of the Royal Society Interface. 2026. doi:10.1098/rsif.2025.1318
BibTeX
@article{Zhang2026,
author = {Zhang, Xiangdong and Wu, Dan and Miao, Fen and Zhong, Jiajie and Yu, Fan and Zhang, Xuejiao and Liu, Hao and Li, Ye},
title = {Personalized haemodynamic modelling for non-invasive quantification of arterial stiffness in the human vasculature},
journal = {Journal of the Royal Society Interface},
year = {2026},
doi = {10.1098/rsif.2025.1318}
}
EUVIMED